Healthcare-associated respiratory syncytial virus infections in children’s hospitals

Background: Little is known about the impact of healthcare-associated respiratory syncytial virus (HA-RSV) in hospitalized children. To address this gap, we assessed the epidemiology and clinical impact associated with HA-RSV in a multiseason, multicenter study. Methods: During respiratory viral sea...

Full description

Bibliographic Details
Main Authors: Lisa Saiman, Susan Coffin, Larry Kociolek, Danielle Zerr, Aaron Milstone, Margaret Aldrich, Celibell Vargas, Morgan Zalot, Megan Reyna, Amanda Adler, Annie Voskertchian, Emily Egbert, Luis Alba, Madelyn Ruggieri, Yoonyoung Choi
Format: Article
Language:English
Published: Cambridge University Press 2022-07-01
Series:Antimicrobial Stewardship & Healthcare Epidemiology
Online Access:https://www.cambridge.org/core/product/identifier/S2732494X22001747/type/journal_article
_version_ 1811157234764218368
author Lisa Saiman
Susan Coffin
Larry Kociolek
Danielle Zerr
Aaron Milstone
Margaret Aldrich
Celibell Vargas
Morgan Zalot
Megan Reyna
Amanda Adler
Annie Voskertchian
Emily Egbert
Luis Alba
Madelyn Ruggieri
Yoonyoung Choi
author_facet Lisa Saiman
Susan Coffin
Larry Kociolek
Danielle Zerr
Aaron Milstone
Margaret Aldrich
Celibell Vargas
Morgan Zalot
Megan Reyna
Amanda Adler
Annie Voskertchian
Emily Egbert
Luis Alba
Madelyn Ruggieri
Yoonyoung Choi
author_sort Lisa Saiman
collection DOAJ
description Background: Little is known about the impact of healthcare-associated respiratory syncytial virus (HA-RSV) in hospitalized children. To address this gap, we assessed the epidemiology and clinical impact associated with HA-RSV in a multiseason, multicenter study. Methods: During respiratory viral seasons 2016–2017, 2017–2018, and 2018–2019, we retrospectively identified HA-RSV cases in hospitalized children 72 hours after admission or within 48 hours of discharge in readmitted patients. Due to reduced availability of testing for non–SARS-CoV-2 viruses during the first year of the COVID-19 pandemic, the 2019–2020 season was excluded. We initiated prospective HA-RSV surveillance during the 2020–2021 season and continued surveillance through November 2021 due to the unusual interseasonal RSV community outbreak. We determined demographic and clinical characteristics of HA-RSV cases and explored possible outcomes associated with RSV including transfer to the pediatric ICU and escalation of respiratory support from day −2 to day +4 (day 0 was the day of RSV detection). We explored the timeframe of day −2 to day +4 because events during this timeframe could be attributed to RSV infection. Respiratory support escalation was defined as change from room air to supplemental oxygen, increase in fraction of inspired oxzygen (FiO2) on same respiratory support modality, or change from noninvasive to invasive support. Results: Were identified 86 HA-RSV cases: 20 (23.3%) from 2016–2017, 26 (30.2%) from 2017–2018, 34 (39.5%) from 2018–2019, and 6 (7%) from October 2020–November 2021. HA-RSV was diagnosed a median of 14 days (IQR, 8–45) after admission. Moreover, 29 (33.7%), 31 (36.0%), and 26 (30.2%) cases were aged 60 months during these, respective seasons. Also, 33 (38.4%) had >3 comorbid conditions, most commonly gastrointestinal (n = 33, 38.4%), respiratory (n = 28, 32.6%), and/or congenital–genetic disorders (n = 28, 32.6%). However, 9 (10.5%) had no comorbid conditions. From day −2 to day +4, 15 children (17.4%) were transferred to the PICU and 38 (49.3%) of 77 evaluable cases required respiratory support escalation, most commonly supplemental oxygen delivered by nasal cannula (n = 15, 19.5%). Furthermore, 11 patients (14.3%) required invasive support. Conclusions: HA-RSV was associated with use of healthcare resources, including the need for respiratory support escalation and/or transfer to intensive care. From October 2020 to November 2021, lower numbers of HA-RSV were observed. The reasons for this are unknown, but potentially occurred in parallel to markedly reduced RSV in the community and may have resulted from visitor restrictions, which included no siblings and/or universal masking by hospital staff and visitors.
first_indexed 2024-04-10T05:02:33Z
format Article
id doaj.art-79343a54dd174128ac6de88842e50648
institution Directory Open Access Journal
issn 2732-494X
language English
last_indexed 2024-04-10T05:02:33Z
publishDate 2022-07-01
publisher Cambridge University Press
record_format Article
series Antimicrobial Stewardship & Healthcare Epidemiology
spelling doaj.art-79343a54dd174128ac6de88842e506482023-03-09T12:28:12ZengCambridge University PressAntimicrobial Stewardship & Healthcare Epidemiology2732-494X2022-07-012s61s6110.1017/ash.2022.174Healthcare-associated respiratory syncytial virus infections in children’s hospitalsLisa SaimanSusan CoffinLarry KociolekDanielle ZerrAaron MilstoneMargaret AldrichCelibell VargasMorgan ZalotMegan ReynaAmanda AdlerAnnie VoskertchianEmily EgbertLuis AlbaMadelyn RuggieriYoonyoung ChoiBackground: Little is known about the impact of healthcare-associated respiratory syncytial virus (HA-RSV) in hospitalized children. To address this gap, we assessed the epidemiology and clinical impact associated with HA-RSV in a multiseason, multicenter study. Methods: During respiratory viral seasons 2016–2017, 2017–2018, and 2018–2019, we retrospectively identified HA-RSV cases in hospitalized children 72 hours after admission or within 48 hours of discharge in readmitted patients. Due to reduced availability of testing for non–SARS-CoV-2 viruses during the first year of the COVID-19 pandemic, the 2019–2020 season was excluded. We initiated prospective HA-RSV surveillance during the 2020–2021 season and continued surveillance through November 2021 due to the unusual interseasonal RSV community outbreak. We determined demographic and clinical characteristics of HA-RSV cases and explored possible outcomes associated with RSV including transfer to the pediatric ICU and escalation of respiratory support from day −2 to day +4 (day 0 was the day of RSV detection). We explored the timeframe of day −2 to day +4 because events during this timeframe could be attributed to RSV infection. Respiratory support escalation was defined as change from room air to supplemental oxygen, increase in fraction of inspired oxzygen (FiO2) on same respiratory support modality, or change from noninvasive to invasive support. Results: Were identified 86 HA-RSV cases: 20 (23.3%) from 2016–2017, 26 (30.2%) from 2017–2018, 34 (39.5%) from 2018–2019, and 6 (7%) from October 2020–November 2021. HA-RSV was diagnosed a median of 14 days (IQR, 8–45) after admission. Moreover, 29 (33.7%), 31 (36.0%), and 26 (30.2%) cases were aged 60 months during these, respective seasons. Also, 33 (38.4%) had >3 comorbid conditions, most commonly gastrointestinal (n = 33, 38.4%), respiratory (n = 28, 32.6%), and/or congenital–genetic disorders (n = 28, 32.6%). However, 9 (10.5%) had no comorbid conditions. From day −2 to day +4, 15 children (17.4%) were transferred to the PICU and 38 (49.3%) of 77 evaluable cases required respiratory support escalation, most commonly supplemental oxygen delivered by nasal cannula (n = 15, 19.5%). Furthermore, 11 patients (14.3%) required invasive support. Conclusions: HA-RSV was associated with use of healthcare resources, including the need for respiratory support escalation and/or transfer to intensive care. From October 2020 to November 2021, lower numbers of HA-RSV were observed. The reasons for this are unknown, but potentially occurred in parallel to markedly reduced RSV in the community and may have resulted from visitor restrictions, which included no siblings and/or universal masking by hospital staff and visitors.https://www.cambridge.org/core/product/identifier/S2732494X22001747/type/journal_article
spellingShingle Lisa Saiman
Susan Coffin
Larry Kociolek
Danielle Zerr
Aaron Milstone
Margaret Aldrich
Celibell Vargas
Morgan Zalot
Megan Reyna
Amanda Adler
Annie Voskertchian
Emily Egbert
Luis Alba
Madelyn Ruggieri
Yoonyoung Choi
Healthcare-associated respiratory syncytial virus infections in children’s hospitals
Antimicrobial Stewardship & Healthcare Epidemiology
title Healthcare-associated respiratory syncytial virus infections in children’s hospitals
title_full Healthcare-associated respiratory syncytial virus infections in children’s hospitals
title_fullStr Healthcare-associated respiratory syncytial virus infections in children’s hospitals
title_full_unstemmed Healthcare-associated respiratory syncytial virus infections in children’s hospitals
title_short Healthcare-associated respiratory syncytial virus infections in children’s hospitals
title_sort healthcare associated respiratory syncytial virus infections in children s hospitals
url https://www.cambridge.org/core/product/identifier/S2732494X22001747/type/journal_article
work_keys_str_mv AT lisasaiman healthcareassociatedrespiratorysyncytialvirusinfectionsinchildrenshospitals
AT susancoffin healthcareassociatedrespiratorysyncytialvirusinfectionsinchildrenshospitals
AT larrykociolek healthcareassociatedrespiratorysyncytialvirusinfectionsinchildrenshospitals
AT daniellezerr healthcareassociatedrespiratorysyncytialvirusinfectionsinchildrenshospitals
AT aaronmilstone healthcareassociatedrespiratorysyncytialvirusinfectionsinchildrenshospitals
AT margaretaldrich healthcareassociatedrespiratorysyncytialvirusinfectionsinchildrenshospitals
AT celibellvargas healthcareassociatedrespiratorysyncytialvirusinfectionsinchildrenshospitals
AT morganzalot healthcareassociatedrespiratorysyncytialvirusinfectionsinchildrenshospitals
AT meganreyna healthcareassociatedrespiratorysyncytialvirusinfectionsinchildrenshospitals
AT amandaadler healthcareassociatedrespiratorysyncytialvirusinfectionsinchildrenshospitals
AT annievoskertchian healthcareassociatedrespiratorysyncytialvirusinfectionsinchildrenshospitals
AT emilyegbert healthcareassociatedrespiratorysyncytialvirusinfectionsinchildrenshospitals
AT luisalba healthcareassociatedrespiratorysyncytialvirusinfectionsinchildrenshospitals
AT madelynruggieri healthcareassociatedrespiratorysyncytialvirusinfectionsinchildrenshospitals
AT yoonyoungchoi healthcareassociatedrespiratorysyncytialvirusinfectionsinchildrenshospitals